SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO LTD has a total of 25 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Taiwan. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SUZHOU KINTOR PHARMACEUTICALS INC, ASCENEURON SA and CROOKS PETER A.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | Australia | 5 | |
#3 | Taiwan | 4 | |
#4 | China | 3 | |
#5 | Singapore | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Lan Jiong | 20 |
#2 | Zhou Fusheng | 17 |
#3 | Lv Qiang | 11 |
#4 | Xie Jing | 11 |
#5 | Jin Yunzhou | 10 |
#6 | Hu Yi | 9 |
#7 | Zhao Jinzhu | 6 |
#8 | Huang Dong | 6 |
#9 | Liu Wei | 5 |
#10 | Chen Yuan | 5 |
Publication | Filing date | Title |
---|---|---|
TW201540713A | Piperidine derivatives as orexin receptor antagonist | |
CN105315285A | 2,4-disubstituted 7H-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medical uses thereof | |
CN104860891A | Arylaminopyrimidine compound and use thereof and pharmaceutical composition and medicinal composition prepared from arylaminopyrimidine compound | |
CN104860941A | 2,4-disubstituted phenyl-1,5-diamine derivatives and use thereof, and pharmaceutical composition and medicinal composition prepared from 2,4-disubstituted phenyl-1,5-diamine derivative |